Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection.
OBJECTIVE
To determine the within-trial and between-trial repeatability of pattern electroretinogram (PERG) measurements in healthy and patient eyes, using a new clinical instrument, the PERGLA.


METHODS
In all, 70 eyes of 35 healthy individuals (intraocular pressure <22 mm Hg, healthy optic disc by stereophotograph assessment, standard visual fields within normal limits) and 90 eyes of 45 clinic patients (ocular hypertensive, glaucomatous optic neuropathy by stereophotograph assessment and/or repeatable abnormal visual fields) enrolled in the University of California, San Diego Diagnostic Innovations in Glaucoma Study (DIGS) were evaluated. Average mean deviation of patient eyes on standard automated perimetry was -1.81 dB (SD=2.61).


METHODS
The PERG was recorded using the PERGLA paradigm from both eyes simultaneously twice (ie, 2 trials) by a single operator with electrodes being removed and reattached between recordings. Repeatability of PERG amplitude (microV) and phase (pi rad) between 2 runs within a single trial (within-trial condition) was compared with repeatability between 2 trials (ie, after electrode replacement, between-trial condition) by calculating the coefficients of variability (CVs) and the intraclass correlation coefficients (ICCs) and displaying Bland-Altman plots.


RESULTS
For healthy eyes, amplitude CVs (SD) were 11.5% (11.5) and 9.9% (0.79) for within-trial and between-trial conditions, respectively. ICCs were 0.91 and 0.85. Phase CVs were 1.3% (1.5) (within-trials) and 1.5% (1.4) (between-trials) and ICCs were 0.85 and 0.88. For patient eyes, amplitude CVs (SD) were 12.2% (10.1) and 11.2% (7.5) for within-trial and between-trial conditions, respectively. ICCs were 0.92 and 0.89. Phase CVs were 2.2% (2.2) (within-trials) and 2.4% (2.2) (between-trials) and ICCs were 0.82 and 0.83. Bland-Altman plots indicated good agreement between the repeated recordings and were similar within-trials and between-trials for healthy and patient eyes.


CONCLUSIONS
Repeatability of PERGLA recordings is good and is similar within-trials and between-trials for both healthy and patient eyes suggesting this technique is promising for monitoring change over time.
Bowd
Christopher
C
Hamilton Glaucoma Center, Department of Ophthalmology, University of California, San Diego, La Jolla, CA 92037-0946, USA. cbowd@glaucoma.ucsd.edu
Tafreshi
Ali
A
Vizzeri
Gianmarco
G
Zangwill
Linda M
LM
Sample
Pamela A
PA
Weinreb
Robert N
RN
D000368:Aged; D004594:Electrophysiology; D004596:Electroretinography; D005260:Female; D005901:Glaucoma / Q000175:diagnosis* / Q000503:physiopathology*; D006801:Humans; D007429:Intraocular Pressure / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000175:diagnosis / Q000503:physiopathology; D015203:Reproducibility of Results; D012160:Retina / Q000503:physiopathology*; D014065:Tonometry, Ocular; D014792:Visual Acuity / Q000502:physiology; D014794:Visual Fields / Q000502:physiology
Ophthalmology. 2008 Jun;115(6):957-63
17976726
Doc Ophthalmol. 1988 Sep;70(1):103-15
3229288
Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1296-302
15790894
Doc Ophthalmol. 2007 May;114(3):111-6
17435967
Ophthalmology. 2004 Jan;111(1):161-8
14711729
Exp Brain Res. 1985;59(2):423-5
4029317
Clin Neurophysiol. 2001 Feb;112(2):351-8
11165541
Ophthalmologica. 1986;192(3):171-5
3725315
Doc Ophthalmol. 1996-1997;92(4):311-23
9476598
Lancet. 1986 Feb 8;1(8476):307-10
2868172
Science. 1981 Feb 27;211(4485):953-5
7466369
Doc Ophthalmol. 1989 Oct;73(2):173-81
2638626
Ophthalmology. 2007 Apr;114(4):671-9
17398319
Am J Ophthalmol. 1983 Jul;96(1):72-83
6869481
Doc Ophthalmol. 1998;95(1):1-14
10189178
Invest Ophthalmol Vis Sci. 1981 Sep;21(3):490-3
7275535
Ophthalmology. 2005 Jan;112(1):10-9
15629814
Invest Ophthalmol Vis Sci. 1999 Mar;40(3):648-56
10067968
Graefes Arch Clin Exp Ophthalmol. 1988;226(6):542-7
3209081